Argosy Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Argosy Research şirketinin toplam hissedar öz sermayesi NT$4.5B ve toplam borcu NT$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NT$5.6B ve NT$1.0B dir. Argosy Research 'in FAVÖK'ü NT$1.0B faiz karşılama oranı -17.1 dur. Şirketin NT$1.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

NT$0

Borç

Faiz karşılama oranı	-17.1x
Nakit	NT$1.34b
Eşitlik	NT$4.50b
Toplam yükümlülükler	NT$1.05b
Toplam varlıklar	NT$5.55b

Son finansal sağlık güncellemeleri

Is Argosy Research (GTSM:3217) Using Too Much Debt?

Feb 28

Recent updates

Are Strong Financial Prospects The Force That Is Driving The Momentum In Argosy Research Inc.'s GTSM:3217) Stock?

Dec 24

The 24% Return On Capital At Argosy Research (GTSM:3217) Got Our Attention

Dec 06

Argosy Research (GTSM:3217) Has Rewarded Shareholders With An Exceptional 999% Total Return On Their Investment

Nov 18

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3217 'nin kısa vadeli varlıkları ( NT$3.2B ) kısa vadeli yükümlülüklerini ( NT$975.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: 3217 şirketinin kısa vadeli varlıkları ( NT$3.2B ) uzun vadeli yükümlülüklerini ( NT$73.7M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3217 borçsuzdur.

Borcun Azaltılması: 3217 şirketinin 5 yıl önce borç/öz sermaye oranı 2.6% iken borcu yok.

Borç Kapsamı: 3217 un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 3217 şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Argosy Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Argosy Research (GTSM:3217) Using Too Much Debt?

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Argosy Research Inc. Announces New Nomination Committee

Argosy Research Inc. to Report Q3, 2024 Results on Nov 01, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Argosy Research Inc. to Report Q2, 2024 Results on Jul 24, 2024

Dividend of NT$6.40 announced

Argosy Research Inc. Approves Cash Dividends, Payable on July 31, 2024

First quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Argosy Research Inc. to Report Q1, 2024 Results on Apr 25, 2024

Price target increased by 14% to NT$200

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued

Argosy Research Inc., Annual General Meeting, Jun 12, 2024

Argosy Research Inc. Announces Resignation of Lu,Cheng-Xi as Chief Internal Auditor, Effective from February 29, 2024

Now 20% undervalued

Investor sentiment improves as stock rises 28%

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Upcoming dividend of NT$5.35 per share at 4.0% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS exceeds analyst expectations

Now 20% undervalued

Now 23% undervalued

Consensus EPS estimates fall by 11%

Price target decreased to NT$81.00

Investor sentiment improved over the past week

Price target decreased to NT$81.00

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$5.60 per share

Consensus revenue estimates fall by 15%

Price target decreased to NT$116

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target increased to NT$160

Investor sentiment improved over the past week

Price target increased to NT$141

Investor sentiment improved over the past week

Price target increased to NT$130

Third quarter 2021 earnings released: EPS NT$2.35 (vs NT$1.95 in 3Q 2020)

Price target decreased to NT$120

Second quarter 2021 earnings released: EPS NT$1.47 (vs NT$1.96 in 2Q 2020)

Upcoming dividend of NT$5.60 per share

Price target decreased to NT$144

Investor sentiment deteriorated over the past week

A Look At The Intrinsic Value Of Argosy Research Inc. (GTSM:3217)

Full year 2020 earnings released: EPS NT$7.20 (vs NT$5.34 in FY 2019)

Will Argosy Research (GTSM:3217) Become A Multi-Bagger?

Is Argosy Research (GTSM:3217) Using Too Much Debt?

New 90-day high: NT$134

How Does Argosy Research Inc. (GTSM:3217) Fare As A Dividend Stock?

New 90-day high: NT$121

Calculating The Fair Value Of Argosy Research Inc. (GTSM:3217)

Is There More To The Story Than Argosy Research's (GTSM:3217) Earnings Growth?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Argosy Research Inc.'s GTSM:3217) Stock?

The 24% Return On Capital At Argosy Research (GTSM:3217) Got Our Attention

Argosy Research (GTSM:3217) Has Rewarded Shareholders With An Exceptional 999% Total Return On Their Investment

Third quarter 2020 earnings released: EPS NT$1.95

New 90-day low: NT$105

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin